An ASNC Information Statement: Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis
Resource Type
Information Statements, Practice Points
Year Published
2022
Related Resources
Posters
Think Amyloid Optimizing Imaging with Tc-99m HMDP_HDP and Tc-99m PYP for Transthyretin Cardiac Amyloidosis Poster
Download now to display in your lab! You may purchase a printed…
Posters
Think Amyloid Multimodality Imaging in the Diagnosis of ATTR-CM Poster
Download now to display in your lab! You may purchase a printed…
Multisociety Letter Supporting ‘Efficiency Adjustment Delay Act of 2026’
ASNC-Multisociety_Final-Efficiency-Adjustment-Delay-Act-Support-Letter_02-12-2026
